sirolimus
Showing 1 - 25 of 331
IgG4-related Disease Trial (Sirolimus)
Not yet recruiting
- IgG4-related Disease
- Sirolimus
- (no location specified)
Feb 25, 2023
Aging Trial (Sirolimus)
Not yet recruiting
- Aging
- Sirolimus
- (no location specified)
Nov 3, 2022
Retroperitoneal Fibrosis Trial in Beijing (Sirolimus, Corticosteroid)
Recruiting
- Retroperitoneal Fibrosis
- Sirolimus
- Corticosteroid
-
Beijing, Beijing, ChinaPeking University International Hospital
Dec 7, 2022
Venous Malformation, Lymphatic Malformation Trial in Charleston (Sirolimus)
Recruiting
- Venous Malformation
- Lymphatic Malformation
- Sirolimus
-
Charleston, South CarolinaMedical University of South Carolina
Nov 7, 2022
Warm Autoimmune Hemolytic Anemia Trial in Beijing (Sirolimus)
Not yet recruiting
- Warm Autoimmune Hemolytic Anemia
- Sirolimus
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Jun 21, 2023
Severe Aplastic Anemia Trial run by the National Heart, Lung, and Blood Institute (NHLBI) (Sirolimus)
Recruiting
- Severe Aplastic Anemia
- Sirolimus
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 27, 2023
Sarcoidosis, Cutaneous Sarcoidosis Trial (Sirolimus)
Not yet recruiting
- Sarcoidosis
- Cutaneous Sarcoidosis
- Sirolimus
- (no location specified)
Jul 12, 2022
Juvenile Nasopharyngeal Angiofibroma Trial in Moscow (Sirolimus)
Recruiting
- Juvenile Nasopharyngeal Angiofibroma
- Sirolimus
-
Moscow, Russian FederationResearch Institute of Pediatric Hematology, Oncology and Immunol
Sep 19, 2022
Graves Ophthalmopathy Trial in Pisa (Sirolimus)
Not yet recruiting
- Graves Ophthalmopathy
- Sirolimus
-
Pisa, ItalyOspedale Cisanello-Endocrinology II
Nov 2, 2022
Bronchiolitis Obliterans Syndrome Due to and After Lung Transplantation (Disorder), Chronic Lung Allograft Dysfunction Trial in
Recruiting
- Bronchiolitis Obliterans Syndrome Due to and After Lung Transplantation (Disorder)
- Chronic Lung Allograft Dysfunction
- Sirolimus
- Placebo
-
San Francisco, CaliforniaUniversity of California, San Francisco
Aug 28, 2023
Genetic Predisposition to Disease, Healthy Volunteers Trial in Columbia (Sirolimus)
Not yet recruiting
- Genetic Predisposition to Disease
- Healthy Volunteers
- Sirolimus
-
Columbia, MissouriUniversity of Missouri-Columbia
Oct 31, 2022
Castleman Disease, Castleman's Disease, Multicentric Trial in Little Rock, La Jolla, Philadelphia (Sirolimus)
Recruiting
- Castleman Disease
- Castleman's Disease, Multicentric
- Sirolimus
-
Little Rock, Arkansas
- +3 more
Jan 6, 2023
Refractory Solid Tumors Trial in Seoul (sirolimus)
Completed
- Refractory Solid Tumors
- sirolimus
-
Seoul, Korea, Republic ofSamsung Medical Center
Jun 13, 2022
Pulmonary Fibrosis, COVID-19 Pneumonia, Long COVID Trial in Chicago (Sirolimus)
Recruiting
- Pulmonary Fibrosis
- +2 more
- Sirolimus
-
Chicago, IllinoisUniversity of Chicago
Nov 18, 2022
Kaposiform Hemangioendothelioma, Kasabach-Merritt Syndrome Trial in Shanghai (Sirolimus)
Recruiting
- Kaposiform Hemangioendothelioma
- Kasabach-Merritt Syndrome
- Sirolimus
-
Shanghai, Shanghai, ChinaChildren's Hospital of Fudan University
Oct 21, 2022
Sirolimus in Graves' Orbitopathy
Completed
- Graves Ophthalmopathy
- Sirolimus
- Methylprednisolone
-
Pisa, PI, ItalyEndocrinologia II
Apr 19, 2022
Complication of Renal Dialysis, End Stage Renal Disease, End Stage Kidney Disease Trial in United States (Sirolimus)
Not yet recruiting
- Complication of Renal Dialysis
- +7 more
- Sirolimus
- (no location specified)
Jun 15, 2022
Vascular Anomaly Trial in Chengdu (Sirolimus)
Completed
- Vascular Anomaly
- Sirolimus
-
Chengdu, Sichuan, ChinaWest China Hospital of Sichuan University
Mar 12, 2022
Hemangioendothelioma Trial in Chengdu (Sirolimus)
Recruiting
- Hemangioendothelioma
- Sirolimus
-
Chengdu, Sichuan, ChinaWest China Hospital of Sichuan University
May 1, 2022
Kaposiform Hemangioendothelioma Trial in Chengdu (Sirolimus)
Recruiting
- Kaposiform Hemangioendothelioma
- Sirolimus
-
Chengdu, Sichuan, ChinaWest China Hospital of Sichuan University
Apr 6, 2022
Kidney Transplant, Delayed Graft Function Trial in Baltimore (Tacrolimus, Sirolimus)
Terminated
- Kidney Transplant
- Delayed Graft Function
- Tacrolimus
- Sirolimus
-
Baltimore, MarylandUniversity of Maryland Medical Center
Mar 29, 2022
Ovarian Serous Tumor, Recurrent Ovarian Carcinoma Trial in Rochester (Auranofin, Laboratory Biomarker Analysis, Sirolimus)
Active, not recruiting
- Ovarian Serous Tumor
- Recurrent Ovarian Carcinoma
- Auranofin
- +2 more
-
Rochester, MinnesotaMayo Clinic
Mar 22, 2022
Graft Vs Host Disease, GVHD Trial in Tampa, Minneapolis (Pacritinib, Sirolimus, Tacrolimus)
Active, not recruiting
- Graft Vs Host Disease
- GVHD
- Pacritinib
- +2 more
-
Tampa, Florida
- +1 more
Jul 27, 2022
Severe Combined Immune Deficiency (SCID) Trial run by the National Institute of Allergy and Infectious Diseases (NIAID)
Enrolling by invitation
- Severe Combined Immune Deficiency (SCID)
- Sirolimus
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 24, 2022
Tuberous Sclerosis Complex, Epilepsy Trial in United States (Sirolimus, Placebo)
Recruiting
- Tuberous Sclerosis Complex
- Epilepsy
- Sirolimus
- Placebo
-
Birmingham, Alabama
- +7 more
Sep 2, 2022